In a report released on March 14, Matthew Biegler from Oppenheimer reiterated a Buy rating on Allogene Therapeutics (ALLO – Research Report), ...

Shares of Nektar Therapeutics (NASDAQ:NKTR) added ~9% in the premarket on Friday after Oppenheimer upgraded the biopharma to ...

In a report released today, Matthew Biegler from Oppenheimer reiterated a Hold rating on Cartesian Therapeutics (RNAC – Research Report). The ...

Expedia Group (NASDAQ:EXPE – Free Report) had its price objective trimmed by Oppenheimer from $235.00 to $230.00 in a ...

Google parent Alphabet has struck a deal to buy cybersecurity startup Wiz for $32 billion in an all-cash transaction, in the tech giant’s largest acquisition ever.

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...

Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...

Remembering Pat, a good friend from Omaha, Neb.

Investing.com - Tesla’s ability to replace some of its consumer base driven away by the political activities of CEO Elon Musk will likely influence the near-term performance of the stock, according to ...

Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...